Genetic susceptibility to hepatoxicity due to bosentan treatment in pulmonary hypertension
Journal Title: Annals of Hepatology - Year 2014, Vol 13, Issue 6
Abstract
Background. Hepatotoxicity is a major side effect of treatment with bosentan in patients with pulmonary hypertension (PH). Bosentan is metabolized by the cytochrome CYP2C9 and inhibits the bile salt export pump, which is encoded by ABCB11. This suggests that genetic variants of CYP2C9 and/or ABCB11 may predispose patients to bosentan-induced liver injury. Material and methods. PH patients with (n = 23) or without (n = 25) an increase of alanine aminotransferase (ALT) or aspartate-aminotransferase (AST) during bosentan therapy were included in our analysis. Functionally relevant alleles of CYP2C9 and 16 representative variants of ABCB11 were genotyped. Data were analyzed using logistic regression. Results. Variants of ABCB11 were not associated with bosentan-induced liver injury. In contrast, variant alleles of CYP2C9 were more common in patients with elevated transaminases (allele frequency 52%) compared to controls (allele frequency 24%, P = 0.04, odds ratio 3.5, 95% confidence interval 1.01-11.8). Conclusion. Our data indicate hepatotoxicity of bosentan from decreased hepatic metabolism due to common variants of CYP2C9.
Authors and Affiliations
Hans-Jürgen Seyfarth, Nadine Favreau, Carsten Tennert, Claudia Ruffert, Michael Halank, Hubert Wirtz, Joachim Mössner, Jonas Rosendahl, Peter Kovacs, Henning Wittenburg
Keywords
Related Articles
- EP ID EP78457
- DOI -
- Views 133
- Downloads 0
Prevalence of insulin resistance in chronic hepatitis C genotype 1 and 3 patients
Background and rationale. Chronic infection with the hepatitis C virus (HCV) is associated with a higher prevalence of insulin resistance compared to the general population. This finding is associated with hepatic steato...
Acute liver failure in under two year-olds - are there markers of metabolic disease on admission?
Introduction. The early establishment of an etiology for acute liver failure (ALF) in infants is essential for the start of adequate treatment in the shortest timeframe possible.Aim. To identify markers of inherited meta...
Dorsal root ganglionopathy in a hepatitis C patient: a case report
We report an unusual clinical presentation of dorsal root ganglionopathy in a hepatitis C patient with negative cryoglobulins characterized by both motor and sensory symptoms. This mixed clinical picture in a hepatitis C...
Meeting the Eastern perspective in hepatitis B related ACLF
Treatment of HCV infection in patients with cirrhosis
The treatment of patients with cirrhosis has the following purposes: to prevent the complications of the disease; to allow for the regression of cirrhosis; and to prevent reinfection in the graft in patients undergoing l...